ALEMBIC PHARMACEUTICALS
|
The Current P/E Ratio of ALEMBIC PHARMACEUTICALS is 33.03.
Share Price | ₹976.5 | Jul 11,2025 |
Market Cap | ₹19,197.0 Cr | |
Earnings-TTM | ₹581.1 Cr | TTM-Consolidated Results |
Price/Earnings | 33.03x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of ALEMBIC PHARMACEUTICALS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹19,197.0 Cr] as on Jul 11,2025
(/) Earnings [ ₹581.1 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 33.03x ]
Thus, for ALEMBIC PHARMACEUTICALS , the investors are currently willing to pay 33.03 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ALEMBIC PHARMACEUTICALS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ALEMBIC PHARMACEUTICALS over the last five years.
Historical PE (Price/Earnings) ratio chart of ALEMBIC PHARMACEUTICALS
PE Ratio Performance Analysis for ALEMBIC PHARMACEUTICALS
- ALEMBIC PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 27.14x.
- ALEMBIC PHARMACEUTICALS 's operated at median p/e ratio of 28.5x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ALEMBIC PHARMACEUTICALS 's p/e ratio peaked in Mar2024 at 31.35x.
- ALEMBIC PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2021 of 16.55x.
How does ALEMBIC PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
ALEMBIC PHARMACEUTICALS | 581.13 | 33.03 | 19,197.0 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,980.10 | 36.55 | 401,289.0 |
DIVIS LABORATORIES LTD | 2,191.00 | 82.79 | 181,397.0 |
CIPLA LTD | 5,291.05 | 22.67 | 119,955.0 |
TORRENT PHARMACEUTICALS LTD | 1,911.00 | 58.68 | 112,132.0 |
DR REDDYS LABORATORIES LTD | 5,703.50 | 18.35 | 104,657.0 |
MANKIND PHARMA LTD | 2,003.22 | 53.11 | 106,401.0 |
ZYDUS LIFESCIENCES LTD | 4,614.80 | 21.36 | 98,570.7 |
LUPIN LTD | 3,306.26 | 26.15 | 86,442.7 |
AUROBINDO PHARMA LTD | 3,515.26 | 18.58 | 65,308.2 |
ABBOTT INDIA LTD | 1,414.44 | 51.69 | 73,118.7 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ALEMBIC PHARMACEUTICALS 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.35x |
Max industry PE | 82.79x |
Median industry PE | 33.03x |
Average industry PE | 38.45x |
You may also like the below Video Courses